ID

34367

Descripción

Stellate Ganglion Block for Hot Flushes in Men Treated With ADT; ODM derived from: https://clinicaltrials.gov/show/NCT02295163

Link

https://clinicaltrials.gov/show/NCT02295163

Palabras clave

  1. 16/1/19 16/1/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

16 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT02295163

Eligibility Prostate Cancer NCT02295163

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male
Descripción

Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
age: >18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
mean daily flush frequency of 10 or more and a hot flush score of 15 or more
Descripción

Flush Daily mean Frequency | Hot flush Score

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0016382
UMLS CUI [1,2]
C0332173
UMLS CUI [1,3]
C0444504
UMLS CUI [1,4]
C0439603
UMLS CUI [2,1]
C0600142
UMLS CUI [2,2]
C0449820
treatment with adt because of prostate cancer
Descripción

Antiandrogen therapy Prostate carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279492
UMLS CUI [1,2]
C0600139
absence of any other cause of flushing
Descripción

Absence Cause Other Flushing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0015127
UMLS CUI [1,3]
C0205394
UMLS CUI [1,4]
C0016382
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of medication that affects flushing: oestrogens, progestogens, clonidine, naloxone, paroxetine, fluoxetine, venlafaxine, gabapentin, luteinizing hormone-releasing hormone receptor antagonist
Descripción

Pharmaceutical Preparations Affecting Flushing | Estrogens | Progestins | Clonidine | Naloxone | Paroxetine | Fluoxetine | venlafaxine | gabapentin | Gonadotropin releasing hormone antagonist

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0016382
UMLS CUI [2]
C0014939
UMLS CUI [3]
C0033306
UMLS CUI [4]
C0009014
UMLS CUI [5]
C0027358
UMLS CUI [6]
C0070122
UMLS CUI [7]
C0016365
UMLS CUI [8]
C0078569
UMLS CUI [9]
C0060926
UMLS CUI [10]
C1268855
still receiving chemotherapy of radiotherapy
Descripción

Chemotherapy | Therapeutic radiology procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
psychiatric disease
Descripción

Mental disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004936
any unstable concurrent disease
Descripción

Disease Unstable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0443343
allergic reactions against bupivacaine or contrast media.
Descripción

Bupivacaine allergy | Contrast media allergy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0570643
UMLS CUI [2]
C0570562

Similar models

Eligibility Prostate Cancer NCT02295163

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender
Item
male
boolean
C0079399 (UMLS CUI [1])
Age
Item
age: >18 years
boolean
C0001779 (UMLS CUI [1])
Flush Daily mean Frequency | Hot flush Score
Item
mean daily flush frequency of 10 or more and a hot flush score of 15 or more
boolean
C0016382 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
C0444504 (UMLS CUI [1,3])
C0439603 (UMLS CUI [1,4])
C0600142 (UMLS CUI [2,1])
C0449820 (UMLS CUI [2,2])
Antiandrogen therapy Prostate carcinoma
Item
treatment with adt because of prostate cancer
boolean
C0279492 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Absence Cause Other Flushing
Item
absence of any other cause of flushing
boolean
C0332197 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0016382 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
Pharmaceutical Preparations Affecting Flushing | Estrogens | Progestins | Clonidine | Naloxone | Paroxetine | Fluoxetine | venlafaxine | gabapentin | Gonadotropin releasing hormone antagonist
Item
use of medication that affects flushing: oestrogens, progestogens, clonidine, naloxone, paroxetine, fluoxetine, venlafaxine, gabapentin, luteinizing hormone-releasing hormone receptor antagonist
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0016382 (UMLS CUI [1,3])
C0014939 (UMLS CUI [2])
C0033306 (UMLS CUI [3])
C0009014 (UMLS CUI [4])
C0027358 (UMLS CUI [5])
C0070122 (UMLS CUI [6])
C0016365 (UMLS CUI [7])
C0078569 (UMLS CUI [8])
C0060926 (UMLS CUI [9])
C1268855 (UMLS CUI [10])
Chemotherapy | Therapeutic radiology procedure
Item
still receiving chemotherapy of radiotherapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Mental disorders
Item
psychiatric disease
boolean
C0004936 (UMLS CUI [1])
Disease Unstable
Item
any unstable concurrent disease
boolean
C0012634 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
Bupivacaine allergy | Contrast media allergy
Item
allergic reactions against bupivacaine or contrast media.
boolean
C0570643 (UMLS CUI [1])
C0570562 (UMLS CUI [2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial